These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 23264301)

  • 21. The human peroxisome proliferator-activated receptor gamma2 (PPARgamma2) Pro12Ala polymorphism is associated with decreased risk of diabetic nephropathy in patients with type 2 diabetes.
    Caramori ML; Canani LH; Costa LA; Gross JL
    Diabetes; 2003 Dec; 52(12):3010-3. PubMed ID: 14633865
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma gene in women with polycystic ovary syndrome.
    Yilmaz M; Ergün MA; Karakoç A; Yurtçu E; Cakir N; Arslan M
    Gynecol Endocrinol; 2006 Jun; 22(6):336-42. PubMed ID: 16785159
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of the Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma in diabetes risk.
    Tönjes A; Stumvoll M
    Curr Opin Clin Nutr Metab Care; 2007 Jul; 10(4):410-4. PubMed ID: 17563457
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Association of variable rs1801282 locus of PPARG2 gene with diabetic nephropathy].
    Avzaletdinova DS; Sharipova LF; Kochetova OV; Morugova TV; Erdman VV; Mustafina OE
    Genetika; 2016 Aug; 52(8):985-90. PubMed ID: 29369552
    [TBL] [Abstract][Full Text] [Related]  

  • 25. D2 Thr92Ala and PPARγ2 Pro12Ala polymorphisms interact in the modulation of insulin resistance in type 2 diabetic patients.
    Estivalet AA; Leiria LB; Dora JM; Rheinheimer J; Bouças AP; Maia AL; Crispim D
    Obesity (Silver Spring); 2011 Apr; 19(4):825-32. PubMed ID: 20930717
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The association between lipid metabolism gene polymorphisms and nephropathy in type 2 diabetes: a meta-analysis.
    Li T; Shi Y; Yin J; Qin Q; Wei S; Nie S; Liu L
    Int Urol Nephrol; 2015 Jan; 47(1):117-30. PubMed ID: 25262148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fetal and maternal peroxisome proliferator-activated receptor gamma2 Pro12Ala does not influence birth weight.
    Pfab T; Poralla C; Richter CM; Godes M; Slowinski T; Priem F; Halle H; Hocher B
    Obesity (Silver Spring); 2006 Nov; 14(11):1880-5. PubMed ID: 17135601
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between the PPARG gene polymorphism and the risk of diabetic nephropathy: a meta-analysis.
    Yu R; Bo H; Huang S
    Genet Test Mol Biomarkers; 2012 May; 16(5):429-34. PubMed ID: 22103651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Pro12Ala polymorphism of the PPAR-gamma2 gene affects associations of fish intake and marine n-3 fatty acids with glucose metabolism.
    Ylönen SK; Salminen I; Lyssenko V; Virtanen SM; Groop L; Aro A; Saloranta C;
    Eur J Clin Nutr; 2008 Dec; 62(12):1432-9. PubMed ID: 17700648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of Pro12Ala polymorphism of PPARgamma gene with insulin resistance and related diseases.
    Horiki M; Ikegami H; Fujisawa T; Kawabata Y; Ono M; Nishino M; Shimamoto K; Ogihara T
    Diabetes Res Clin Pract; 2004 Dec; 66 Suppl 1():S63-7. PubMed ID: 15563983
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of the PPAR-gamma2 Pro12Ala and ACE I/D polymorphisms on insulin sensitivity and training effects in healthy offspring of type 2 diabetic subjects.
    Østergård T; Ek J; Hamid Y; Saltin B; Pedersen OB; Hansen T; Schmitz O
    Horm Metab Res; 2005 Feb; 37(2):99-105. PubMed ID: 15778927
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Peroxisome proliferator-activated receptor-gamma2 Pro12Ala and endothelial nitric oxide synthase-4a/b gene polymorphisms are not associated with hypertension in diabetes mellitus type 2.
    Gouni-Berthold I; Giannakidou E; Müller-Wieland D; Faust M; Kotzka J; Berthold HK; Krone W
    J Hypertens; 2005 Feb; 23(2):301-8. PubMed ID: 15662218
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Mutations of peroxisome proliferator-activated receptor gamma (PPARgamma): clinical implications].
    Gacka M; Adamiec R
    Postepy Hig Med Dosw (Online); 2004; 58():483-9. PubMed ID: 15765009
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Studies of the Pro12Ala polymorphism of the peroxisome proliferator-activated receptor-gamma2 (PPAR-gamma2) gene in relation to insulin sensitivity among glucose tolerant caucasians.
    Ek J; Andersen G; Urhammer SA; Hansen L; Carstensen B; Borch-Johnsen K; Drivsholm T; Berglund L; Hansen T; Lithell H; Pedersen O
    Diabetologia; 2001 Sep; 44(9):1170-6. PubMed ID: 11596673
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of Pro12Ala polymorphism in peroxisome proliferator-activated receptor-γ2 gene on metabolic syndrome risk: a meta-analysis.
    Zhang R; Wang J; Yang R; Sun J; Chen R; Luo H; Liu D; Cai D
    Gene; 2014 Feb; 535(1):79-87. PubMed ID: 24012868
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Ala allele in the PPAR-gamma2 gene is associated with reduced risk of type 2 diabetes mellitus in Caucasians and improved insulin sensitivity in overweight subjects.
    Huguenin GV; Rosa G
    Br J Nutr; 2010 Aug; 104(4):488-97. PubMed ID: 20420754
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An analysis of peroxisome proliferator-activated receptor gamma (PPAR-gamma 2) Pro12Ala polymorphism distribution and prevalence of type 2 diabetes mellitus (T2DM) in world populations in relation to dietary habits.
    Scacchi R; Pinto A; Rickards O; Pacella A; De Stefano GF; Cannella C; Corbo RM
    Nutr Metab Cardiovasc Dis; 2007 Nov; 17(9):632-41. PubMed ID: 17434720
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with Pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals.
    Tönjes A; Scholz M; Loeffler M; Stumvoll M
    Diabetes Care; 2006 Nov; 29(11):2489-97. PubMed ID: 17065690
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for interaction between PPARG Pro12Ala and PPARGC1A Gly482Ser polymorphisms in determining type 2 diabetes intermediate phenotypes in overweight subjects.
    Ruchat SM; Weisnagel SJ; Vohl MC; Rankinen T; Bouchard C; Pérusse L
    Exp Clin Endocrinol Diabetes; 2009 Oct; 117(9):455-9. PubMed ID: 19536736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects.
    Kawasaki I; Tahara H; Emoto M; Shoji T; Shioji A; Okuno Y; Inaba M; Nishizawa Y
    Osaka City Med J; 2002 Jun; 48(1):23-8. PubMed ID: 12375694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.